Brightline Strategies contracted KDS to tackle the redesign of the QRx Pharma website. QRxPharma Limited is a commercial-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management and central nervous system (CNS) disorders.

KDS also works with Brighline Strategies on the QRx Pharma Annual Report, as well as other materials such as animated graphics and charts for PowerPoint presentations.

view site >